Boill Healthcare Holdings (HKSE:01246) Common Stock: HK$339.5 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01246 Boill Healthcare Holdings Ltd HKSE:01246
4 GF Score
Price HK$0.02
! 8 Warning Signs
View Full Analysis

What is Boill Healthcare Holdings Common Stock?

Boill Healthcare Holdings HKSE:01246 4 Common Stock is HK$339.5 Mil as of Sep. 2025. GuruFocus rates HKSE:01246 with a GF Score™ of 4/100. The stock has 8 warning signs investors should review.

Boill Healthcare Holdings's quarterly common stock stayed the same from Sep. 2024 (HK$339.5 Mil) to Mar. 2025 (HK$339.5 Mil) and stayed the same from Mar. 2025 (HK$339.5 Mil) to Sep. 2025 (HK$339.5 Mil).

Boill Healthcare Holdings's annual common stock stayed the same from Mar. 2023 (HK$339.5 Mil) to Mar. 2024 (HK$339.5 Mil) and stayed the same from Mar. 2024 (HK$339.5 Mil) to Mar. 2025 (HK$339.5 Mil).


Boill Healthcare Holdings Common Stock Historical Data

* Premium members only.

The historical data trend for Boill Healthcare Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boill Healthcare Holdings Common Stock Chart

Boill Healthcare Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 339.50 339.50 339.50 339.50 339.50

Boill Healthcare Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 339.50 339.50 339.50 339.50 339.50
HKSE:01246
4GF Score
Boill Healthcare Holdings Ltd HKSE:01246
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boill Healthcare Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of HK$339.5 Mil mean?
Boill Healthcare Holdings (HKSE:01246) has a Common Stock of HK$339.5 Mil as of Sep. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Boill Healthcare Holdings and its competitors.
Is Boill Healthcare Holdings' Common Stock too high?
Boill Healthcare Holdings' current Common Stock is HK$339.5 Mil. Overall, Boill Healthcare Holdings has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Boill Healthcare Holdings' Common Stock compare to competitors?
Boill Healthcare Holdings' Common Stock of HK$339.5 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Real Estate company?
A good Common Stock depends on the Real Estate industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Boill Healthcare Holdings and its competitors. Boill Healthcare Holdings's current Common Stock is HK$339.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boill Healthcare Holdings stock overvalued right now?
Boill Healthcare Holdings (HKSE:01246) has a current Common Stock of HK$339.5 Mil. The current Common Stock is HK$339.5 Mil. Boill Healthcare Holdings' overall GF Score™ is 4/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Boill Healthcare Holdings (HKSE:01246), the current Common Stock is HK$339.5 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Boill Healthcare Holdings Business Description

Address 167-169 Hennessy Road, 15th Floor, Toi Shan Association Building, Wan Chai, Hong Kong, HKG
Boill Healthcare Holdings Ltd is an investment holding company. Along with its subsidiaries, it operates in the property development segment, which includes the sale of properties, sales of construction materials, and the provision of property management services. The Group generates maximum revenue from the sales of properties. Additionally, it is focused on developing its business in the healthcare and leisure segment through the distribution of herbal tea, grain-related drinks, huangjiu and other Chinese liquor products, and other fast moving consumable goods. Geographically, the Group generates all of its revenue from the People's Republic of China (PRC).
4GF Score

Get the complete analysis for HKSE:01246

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.02
Price